ARCHIVES

Gene Therapy Alters Immune Cells For Treatment Of Advanced Melanoma

This article is from The Cancer Letter archive.

Vol. 29 No. 9 | September 29, 2006

Download PDF Visit The Full Archive

Related Articles

Tivozanib Does Not Improve OS Compared to Sorafenib

February 22, 2013

Vanderbilt-Ingram Cancer Center Wins NCI’s Comprehensive Designation.

March 16, 2001

Asks BSC For Advice On Centers Funding, Other Pressing Issues, But Doesn’t Get Any

March 30, 1990

Major Changes In NCI Drug screening Tumor Panels Approved

June 18, 1982

Gregory Reaman Named Associate Director of FDA Office of Oncology Drug Products

June 3, 2011

Wendy Will Case Found Invites Applications For Small Grants

April 5, 1991